From 500g to 50 kg: short and long-term cardiovascular impact of prematurity

Friday, April 28, 2023

3:45 PM – 5:15 PM ET

Location: Convention Center: 146 B

CE: Live CME: 1.50

Selected By: Neonatal

Chair(s)

Audrey Hebert, MD, FRCPC

Neonatologist
Faculty of Medicine Université Laval
Quebec city, Quebec, Canada
Gabriel Altit, MDCM, MSc, FRCPC, FAAP (he/him/his)

Assistant Professor - Neonatologist - Montreal Children's Hospital
McGill University Faculty of Medicine and Health Sciences
Montreal, Quebec, Canada

Disclosure(s):

Audrey Hebert, MD, FRCPC: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Gabriel Altit, MDCM, MSc, FRCPC, FAAP: MedTronic (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

Session

Description: Extremely premature newborns are increasingly surviving with a higher burden of lung-airway-pulmonary vasculature injury via various pre- and post-natal processes. These infants have a spectrum of bronchopulmonary and pulmonary vascular disease that may have a lifelong impact. Recently, there has been an increased awareness for post-natal pulmonary hypertension and the significant impacts of altered pulmonary function and airway anomalies in infants. Neonatologists, with support from multidisciplinary teams, are frequently managing premature infants with pulmonary vascular disease secondary to prematurity in the neonatal care unit (NICU). Once discharged from the NICU, these patients receive regular neuro-developmental follow-up, however cardiovascular follow-up has yet to become standard of care. Prematurity is a major risk factor for cardiovascular disease during childhood and adolescence, and should be acknowledged by teams involved in their care. This session will explore the short- and long-term impact of prematurity on pulmonary and cardiovascular health with experts in the field. The audience will be taking on a hemodynamic and cardiovascular journey from the NICU to young adulthood, with emphasis on risk factors, physiopathology, clinical presentation, screening guidelines and management of pulmonary vascular disease

Learning Objectives:

To describe the physiopathology, risk factors and presentation of chronic pulmonary hypertension associated with BPD in preterm infants.
To become familiar with the evolution in time, clinical presentation and potential complications of prematurity on the pulmonary vasculature and heart during childhood.
To recognize the long-term impact of prematurity on cardiovascular health in the follow-up of adolescents and young adults born preterm.

Presentations:

3:45 PM – 4:00 PM ET

Chronic pulmonary hypertension in BPD in the NICU: should we screen and why do we care?
Speaker: Audrey Hebert, MD, FRCPC – Faculty of Medicine Université Laval
4:00 PM – 4:15 PM ET

Chronic pulmonary hypertension in BPD in the NICU: when the left and right heart become problematic
Speaker: Gabriel Altit, MDCM, MSc, FRCPC, FAAP (he/him/his) – McGill University Faculty of Medicine and Health Sciences
4:15 PM – 4:30 PM ET

After NICU discharge: special cardiovascular considerations and when to worry in children born preterm
Speaker: Steve Abman, MD (he/him/his) – University of Colorado School of Medicine
4:30 PM – 4:45 PM ET

The adolescent born preterm - impact on cardiovascular system, pulmonary system and outcomes
Speaker: Anne Monique Nuyt, MD (she/her/hers) – Universite de Montreal Faculty of Medicine
4:45 PM – 5:00 PM ET

From the NICU to the adult world: Pulmonary vascular disease in young adults born preterm
Speaker: Kara Goss, MD – University of Texas Southwestern Medical School